Christopher Mengler joins Impax
This article was originally published in Scrip
Executive Summary
Impax Laboratories (US) has appointed Christopher Mengler president of Global Pharmaceuticals, the company's generic pharmaceutical division. He joins from Barr Laboratories, where he was most recently executive vice-president of global strategic planning.